{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:17:49Z","timestamp":1792808269293,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006244","name":"Stichting Kinderen Kankervrij","doi-asserted-by":"publisher","award":["268"],"award-info":[{"award-number":["268"]}],"id":[{"id":"10.13039\/501100006244","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ejca.2023.03.039","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T11:24:46Z","timestamp":1680866686000},"page":"124-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia\u2014results of a double-blind, randomised controlled trial with cross-over design"],"prefix":"10.1016","volume":"187","author":[{"given":"Annelienke M.","family":"van Hulst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L.T.","family":"van den Akker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma J.","family":"Verwaaijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Fiocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00eble R.L.","family":"van Litsenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia M.F.","family":"Pluijm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Michel","family":"Zwaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke M.","family":"van Santen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea W.M.","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha A.","family":"Grootenhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marry M.","family":"van den Heuvel-Eibrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ejca.2023.03.039_bib1","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41375-020-01024-0","article-title":"Progress against childhood and adolescent acute lymphoblastic leukaemia in the Netherlands, 1990-2015","volume":"35","author":"Reedijk","year":"2021","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.ejca.2023.03.039_bib2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/MPH.0b013e318257fdac","article-title":"Corticosteroids, behavior, and quality of life in children treated for acute lymphoblastic leukemia; a multicentered trial","volume":"34","author":"Pound","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2023.03.039_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/01460860903486572","article-title":"Corticosteroids during continuation therapy for acute lymphoblastic leukemia: the psycho-social impact","volume":"33","author":"McGrath","year":"2010","journal-title":"Issues Compr Pediatr Nurs"},{"issue":"12","key":"10.1016\/j.ejca.2023.03.039_bib4","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1016\/j.pec.2021.04.015","article-title":"The efficacy of interactive group psychoeducation for children with leukaemia:\u00a0a\u00a0randomised controlled trial","volume":"104","author":"Day","year":"2021","journal-title":"Patient Educ Couns"},{"issue":"2","key":"10.1016\/j.ejca.2023.03.039_bib5","first-page":"146","article-title":"'Enough is enough': qualitative findings on the impact of dexamethasone during reinduction\/consolidation for paediatric acute lymphoblastic leukaemia","volume":"10","author":"McGrath","year":"2002","journal-title":"Support Care Cancer"},{"issue":"8","key":"10.1016\/j.ejca.2023.03.039_bib6","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1210\/en.2014-1048","article-title":"From receptor balance to rational glucocorticoid therapy","volume":"155","author":"de Kloet","year":"2014","journal-title":"Endocrinology"},{"issue":"2\u20133","key":"10.1016\/j.ejca.2023.03.039_bib7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ejphar.2007.07.072","article-title":"Mineralocorticoid receptors in brain, in health and disease: possibilities for new pharmacotherapy","volume":"583","author":"Kellner","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.ejca.2023.03.039_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1530\/eje.0.1510397","article-title":"Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties","volume":"151","author":"Grossmann","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.ejca.2023.03.039_bib9","first-page":"55","article-title":"How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions","volume":"21","author":"Sapolsky","year":"2000","journal-title":"Endocr Rev"},{"issue":"19","key":"10.1016\/j.ejca.2023.03.039_bib10","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1200\/JCO.2015.66.0761","article-title":"Hydrocortisone as an intervention for dexamethasone-induced adverse effects in pediatric patients with acute lymphoblastic leukemia: results of a double-blind, randomized controlled trial","volume":"34","author":"Warris","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2023.03.039_bib11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12887-021-02896-6","article-title":"Study protocol: DexaDays-2, hydrocortisone for treatment of dexamethasone-induced neurobehavioral side effects in pediatric leukemia patients: a double-blind placebo controlled randomized intervention study with cross-over design","volume":"21","author":"van Hulst","year":"2021","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.ejca.2023.03.039_bib12","unstructured":"Netherlands Trial Register. Available from: \u3008https:\/\/www.trialregister.nl\u3009. Accessed 10-03-2023."},{"issue":"1","key":"10.1016\/j.ejca.2023.03.039_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12955-018-0948-1","article-title":"Dutch norms for the Strengths and Difficulties Questionnaire (SDQ) - parent form for children aged 2-18 years","volume":"16","author":"Maurice-Stam","year":"2018","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"10.1016\/j.ejca.2023.03.039_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00787-003-0341-3","article-title":"Dutch version of the Strengths and Difficulties Questionnaire (SDQ)","volume":"12","author":"van Widenfelt","year":"2003","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"5","key":"10.1016\/j.ejca.2023.03.039_bib15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1469-7610.1997.tb01545.x","article-title":"The Strengths and Difficulties Questionnaire: a research note","volume":"38","author":"Goodman","year":"1997","journal-title":"J Child Psychol Psychiatry"},{"issue":"11","key":"10.1016\/j.ejca.2023.03.039_bib16","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/00004583-200111000-00015","article-title":"Psychometric properties of the strengths and difficulties questionnaire","volume":"40","author":"Goodman","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"10.1016\/j.ejca.2023.03.039_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00787-003-0298-2","article-title":"The Strengths and Difficulties Questionnaire (SDQ)--further evidence for its reliability and validity in a community sample of Dutch children and adolescents","volume":"12","author":"Muris","year":"2003","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"4","key":"10.1016\/j.ejca.2023.03.039_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2869.1996.00251.x","article-title":"The Sleep Disturbance Scale for Children (SDSC). Construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence","volume":"5","author":"Bruni","year":"1996","journal-title":"J Sleep Res"},{"issue":"1","key":"10.1016\/j.ejca.2023.03.039_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/sj.ijo.0801083","article-title":"Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies","volume":"24","author":"Flint","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"12","key":"10.1016\/j.ejca.2023.03.039_bib20","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S2213-8587(20)30364-8","article-title":"Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials","volume":"8","author":"Clement","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"10.1016\/j.ejca.2023.03.039_bib21","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/cncr.10428","article-title":"The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module","volume":"94","author":"Varni","year":"2002","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2023.03.039_bib22","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jpeds.2013.06.011","article-title":"Development and validation of the distress thermometer for parents of a chronically ill child","volume":"163","author":"Haverman","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.ejca.2023.03.039_bib23","unstructured":"CTCAE v5.0. Available from: \u3008https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm#ctc_50\u3009. Accessed 29-07-2022."},{"issue":"12","key":"10.1016\/j.ejca.2023.03.039_bib24","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1200\/JCO.2007.13.8404","article-title":"Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia","volume":"26","author":"Yang","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2023.03.039_bib25","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s11136-019-02365-9","article-title":"Determinants of health-related quality of life proxy rating disagreement between caregivers of children with cancer","volume":"29","author":"Rensen","year":"2020","journal-title":"Qual Life Res"},{"issue":"7","key":"10.1016\/j.ejca.2023.03.039_bib26","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/pon.5654","article-title":"Risk factors for steroid-induced adverse psychological reactions and sleep problems in pediatric acute lymphoblastic leukemia: a\u00a0systematic review","volume":"30","author":"van Hulst","year":"2021","journal-title":"Psychooncology"},{"issue":"6","key":"10.1016\/j.ejca.2023.03.039_bib27","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jama.2012.115","article-title":"Nocebo effects, patient-clinician communication, and therapeutic outcomes","volume":"307","author":"Colloca","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2023.03.039_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/bs.irn.2018.02.005","article-title":"Nocebo effects: neurobiological mechanisms and strategies for prevention and optimizing treatment","volume":"138","author":"Kleine-Borgmann","year":"2018","journal-title":"Int Rev Neurobiol"},{"issue":"6","key":"10.1016\/j.ejca.2023.03.039_bib29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1056\/NEJMra1907805","article-title":"Placebo and nocebo effects","volume":"382","author":"Colloca","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2023.03.039_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fpsyt.2020.00169","article-title":"\"Placebo by proxy\" and \"nocebo by proxy\" in children: a review of parents' role in treatment outcomes","volume":"11","author":"Czerniak","year":"2020","journal-title":"Front Psychiatry"},{"issue":"1","key":"10.1016\/j.ejca.2023.03.039_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1546-0096-11-23","article-title":"Mothers\u2019 reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life","volume":"11","author":"Mulligan","year":"2013","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.ejca.2023.03.039_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2022.103202","article-title":"Stress-level glucocorticoids increase fasting hunger and decrease cerebral blood flow in regions regulating eating","volume":"36","author":"Bini","year":"2022","journal-title":"Neuroimage Clin"},{"key":"10.1016\/j.ejca.2023.03.039_bib33","doi-asserted-by":"crossref","first-page":"d4345","DOI":"10.1136\/bmj.d4345","article-title":"Placebo by proxy","volume":"343","author":"Grelotti","year":"2011","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ejca.2023.03.039_bib34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1124\/pr.114.009423","article-title":"Neuro-bio-behavioral mechanisms of placebo and nocebo responses: implications for clinical trials and clinical practice","volume":"67","author":"Schedlowski","year":"2015","journal-title":"Pharmacol Rev"},{"issue":"4","key":"10.1016\/j.ejca.2023.03.039_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000085651","article-title":"Mechanisms of the placebo effect and of conditioning","volume":"12","author":"Haour","year":"2005","journal-title":"Neuroimmunomodulation"},{"issue":"4","key":"10.1016\/j.ejca.2023.03.039_bib36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/clpt.1992.157","article-title":"Classic conditioning and placebo effects in crossover studies","volume":"52","author":"Suchman","year":"1992","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ejca.2023.03.039_bib37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2214.2007.00743.x","article-title":"Children's and parents' perspectives on open-label use of placebos in the treatment of ADHD","volume":"34","author":"Sandler","year":"2008","journal-title":"Child Care Health Dev"},{"issue":"4","key":"10.1016\/j.ejca.2023.03.039_bib38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000490354","article-title":"Implications of placebo and nocebo effects for clinical practice: expert consensus","volume":"87","author":"Evers","year":"2018","journal-title":"Psychother Psychosom"},{"issue":"4","key":"10.1016\/j.ejca.2023.03.039_bib39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/jamapediatrics.2021.5750","article-title":"Effect of open-label placebo on children and adolescents with functional abdominal pain or irritable bowel syndrome: a randomized clinical trial","volume":"176","author":"Nurko","year":"2022","journal-title":"JAMA Pediatr"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923001740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923001740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:41:28Z","timestamp":1760733688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804923001740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":39,"alternative-id":["S0959804923001740"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2023.03.039","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia\u2014results of a double-blind, randomised controlled trial with cross-over design","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2023.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2023.112979","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2023.112980","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}